Michael D. Mulholland
2020 - CytoDyn
In 2020, Michael D. Mulholland earned a total compensation of $684.7K as Chief Financial Officer at CytoDyn, a 33% increase compared to previous year.
Compensation breakdown
| Option Awards | $239,258 |
|---|---|
| Salary | $427,179 |
| Other | $18,252 |
| Total | $684,689 |
Mulholland received $427.2K in salary, accounting for 62% of the total pay in 2020.
Mulholland also received $239.3K in option awards and $18.3K in other compensation.
Rankings
In 2020, Michael D. Mulholland's compensation ranked 10,041st out of 13,090 executives tracked by ExecPay. In other words, Mulholland earned more than 23.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,041 out of 13,090 | 23rd |
Division Manufacturing | 4,315 out of 5,620 | 23rd |
Major group Chemicals And Allied Products | 1,775 out of 2,253 | 21st |
Industry group Drugs | 1,553 out of 1,953 | 21st |
Industry Pharmaceutical Preparations | 1,145 out of 1,458 | 22nd |
Source: SEC filing on September 1, 2020.
Mulholland's colleagues
We found three more compensation records of executives who worked with Michael D. Mulholland at CytoDyn in 2020.